These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunogenic targets in non-small cell lung cancer: more is more. Gnjatic S Clin Cancer Res; 2005 Aug; 11(15):5331-2. PubMed ID: 16061843 [No Abstract] [Full Text] [Related]
6. To Treat or Not to Treat: Role of Immunotherapy in Patients with Concomitant Diagnosis of Advanced-Stage Non-Small Cell Lung Cancer and Psoriasis. Khunger M; Calabrese C; Kontzias A; Velcheti V J Thorac Oncol; 2017 Sep; 12(9):e147-e149. PubMed ID: 28838717 [No Abstract] [Full Text] [Related]
7. New strategies in lung cancer: translating immunotherapy into clinical practice. Forde PM; Kelly RJ; Brahmer JR Clin Cancer Res; 2014 Mar; 20(5):1067-73. PubMed ID: 24470514 [TBL] [Abstract][Full Text] [Related]
8. Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer. Kakimi K; Nakajima J; Wada H Lung Cancer; 2009 Jul; 65(1):1-8. PubMed ID: 19062127 [TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for non-small cell lung cancer: are we on the cusp of a new era? Waqar SN; Morgensztern D Expert Rev Clin Immunol; 2015; 11(8):871-3. PubMed ID: 26051156 [TBL] [Abstract][Full Text] [Related]
11. Immunotherapy in non-small-cell lung carcinoma: from inflammation to vaccination. Van den Heuvel MM; Burgers SA; van Zandwijk N Clin Lung Cancer; 2009 Mar; 10(2):99-105. PubMed ID: 19362952 [TBL] [Abstract][Full Text] [Related]
12. [Non-small cell lung cancer: news from immunotherapy]. Reinmuth N; Heigener DF; Reck M Dtsch Med Wochenschr; 2015 Mar; 140(5):329-33. PubMed ID: 25734674 [TBL] [Abstract][Full Text] [Related]
13. [Immuno-Oncology therapeutic principles in lung and renal cell carcinoma]. Wolf J; Grünwald V Oncol Res Treat; 2014; 37 Suppl 4():10-3. PubMed ID: 25301191 [No Abstract] [Full Text] [Related]
14. Is vaccine therapy a renewed strategic approach for non-small-cell lung cancer therapy? Rossi A Expert Rev Vaccines; 2013 Jan; 12(1):5-7. PubMed ID: 23256734 [No Abstract] [Full Text] [Related]
15. [Progress in Immunotherapy for Squamous Non-small Cell Lung Cancer]. Wang S; Li J Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):682-686. PubMed ID: 27760599 [TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy. Zheng H; Zeltsman M; Zauderer MG; Eguchi T; Vaghjiani RG; Adusumilli PS Immunotherapy; 2017 Sep; 9(11):913-927. PubMed ID: 29338609 [TBL] [Abstract][Full Text] [Related]
17. The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer. Santana-Davila R; Chow LQ Future Oncol; 2018 Feb; 14(3):191-194. PubMed ID: 29334785 [No Abstract] [Full Text] [Related]
18. Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-Introduction. Socinski MA Semin Oncol; 2015 Oct; 42 Suppl 2():S1-2. PubMed ID: 26477469 [No Abstract] [Full Text] [Related]
19. Targeted Therapy and Immunotherapy for Lung Cancer. Naylor EC; Desani JK; Chung PK Surg Oncol Clin N Am; 2016 Jul; 25(3):601-9. PubMed ID: 27261918 [TBL] [Abstract][Full Text] [Related]